A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism

Clinical trial NCT03108833 · COMPLETED

Trial details

NCT number: NCT03108833
Sponsor: Tasly Biopharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Pulmonary Embolism

Start date: 2017-06-06
Primary completion: 2019-12-19
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.